Volitionrx (VNRX) Net Margin Growth (3y) (2022 - 2025)

Volitionrx (VNRX) Net Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 182.81 Bn 175.52 Bn 6.27 Bn -388.00
2 Stryker 128.98 Bn 126.10 Bn 3.81 Bn -1.00
3 Medtronic 108.67 Bn 99.45 Bn 6.41 Bn -108.00
4 Boston Scientific 68.36 Bn 66.91 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 47.70 Bn 44.03 Bn 1.29 Bn -
6 Dexcom 28.67 Bn 27.55 Bn 750.30 Mn 1,018.00
7 GE HealthCare Technologies 28.55 Bn 26.27 Bn 1.98 Bn 399.00
8 Smith & Nephew 26.97 Bn 26.40 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn 1,978.00
10 Volitionrx 92,593.09 -1.02 Mn - -712,170.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -712,170.00
Sep 30, 2025 3.89 Mn
Jun 30, 2025 -19,479.00
Mar 31, 2025 -248,286.00
Dec 31, 2024 5.16 Mn
Sep 30, 2024 2.66 Mn
Jun 30, 2024 -268,928.00
Mar 31, 2024 -499,987.00
Dec 31, 2023 -1.33 Mn
Sep 30, 2023 -796,376.00
Jun 30, 2023 -448,969.00
Mar 31, 2023 106.00 Mn
Dec 31, 2022 2.89 Mn